MMRGlobal Projects Record 1st Quarter Revenue
LOS ANGELES, CA--(Marketwired - Mar 20, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR" or the "Company") today announced that it
projects first quarter 2014 revenue from all sources to be among
the highest in the Company's history driven by licensing and
Personal Health Record sales. The Company also announced that all
licensing and sales agreements up for renewal to date in 2014 have
been renewed for at least another year. Much of the revenue that
has already been received by the Company is a result of licensing
from the Company's MyMedicalRecords, Inc. patent portfolio. MMR
also projects significantly increased revenues starting in the
second quarter of 2014 from retailer and direct-to-consumer sales
help driven by increasing interest in maintaining a Personal Health
Record as a result of millions spent by the government on
advertising HealthCare.gov.
Additionally, the Company forecasts continued revenue from its
biotechnology assets based on the latest information available to
the Company pursuant to the terms of its thirteen million dollar
biotech licensing agreement, which is the subject of an 8-K filed
on December 21, 2010. The Company also has begun entering into
agreements with licensed medical cannabis dispensaries to sell
Personal Health Records direct to consumers at retail.
MyMedicalRecords, Inc. has also filed patent infringement
complaints against Allscripts Healthcare Solutions, Inc., Jardogs,
Quest Diagnostics, Inc. and WebMD for infringement of two of its
ten U.S. health IT patents: U.S. Patent No. 8,301,466 and U.S.
Patent No. 8,498,883. MMR's patent portfolio also includes U.S.
Patent Nos. 8,121,855; 8,117,045; 8,117,646; 8,321,240; 8,352,287;
8,352,288; 8,626,532 and 8,645,161, as well as numerous pending
applications. MMR also owns additional HIT patents in 11 other
countries or regional territories of commercial interest including
Australia, Singapore, New Zealand, Mexico, Japan, Canada, China,
Hong Kong, South Korea, Israel and Europe. MMR is also continuing
licensing talks with EMR vendors and others in the United States,
Australia and Israel regarding licensing and sales of its health IT
patents, products and services.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, and
professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access
their medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using
a variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records
and sharing them with patients in real time through an integrated
patient portal. MMR is an Independent Software Vendor Partner with
Kodak to deliver an integrated turnkey EMR solution for healthcare
professionals. Through its merger with Favrille, Inc. in January
2009, the Company acquired intellectual property biotech assets
that include anti-CD20 antibodies and data and samples from its
FavId™/Specifid™ vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit www.mmrglobal.com. View demos and video tutorials of the
Company's products and services at www.mmrtheater.com.
Forward-Looking Statements All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance.
Such statements are necessarily based on assumptions and estimates
and are subject to various risks and uncertainties, including those
relating to the possible invalidity of the underlying assumptions
and estimates and possible changes or developments in economic,
business, industry, market, legal and regulatory circumstances and
conditions and actions taken or omitted to be taken by third
parties, including customers, suppliers, business partners,
potential licensees, competitors and legislative, judicial and
other governmental authorities and officials. Factors that could
cause or contribute to such differences include, but are not
limited to: unexpected outcomes with respect to intellectual
property enforcement actions, claims of intellectual property
infringement and general intellectual property litigation; our
ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business
prospects, results of operations or financial condition; risks
related to the current uncertainty and instability in financial and
lending markets, including global economic uncertainties; the
timing and volume of sales and installations; the length of sales
cycles and the installation process; the market's acceptance of new
product and service introductions; competitive product offerings
and promotions; changes in government laws and regulations
including the 2009 HITECH Act and changes in Meaningful Use and the
2010 Affordable Care Act; future changes in tax legislation and
initiatives in the healthcare industry; undetected errors in our
products; the possibility of interruption at our data centers;
risks related to third party vendors; risks related to obtaining
and integrating third-party licensed technology; risks related to a
security breach by third parties; risks associated with recruitment
and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in MMR's
filings with the Securities and Exchange Commission. MMR is
providing this information as of the date of this release and,
except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in
this release as a result of new information, future events or
otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033